Dr William H Bay, MD | |
595 Copeland Mill Rd, Suite 2d, Westerville, OH 43081-8908 | |
(614) 823-8500 | |
(614) 823-8501 |
Full Name | Dr William H Bay |
---|---|
Gender | Male |
Speciality | Internal Medicine - Nephrology |
Location | 595 Copeland Mill Rd, Westerville, Ohio |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104825736 | NPI | - | NPPES |
0279372 | Medicaid | OH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 35033631 (Ohio) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr William H Bay, MD 595 Copeland Mill Rd, Suite 2d, Westerville, OH 43081-8908 Ph: (614) 823-8500 | Dr William H Bay, MD 595 Copeland Mill Rd, Suite 2d, Westerville, OH 43081-8908 Ph: (614) 823-8500 |
News Archive
EVOLVE WELLNESS CENTER, Los Angeles' premier Acupuncture group for more than 13 years has expanded to a prominent new space in West Hollywood and is planning to celebrate its Grand Re-Opening with a great deal of fanfare.
Building off recent laboratory discoveries relating to how cancer cells become resistant to therapies that attempt to starve cancer, scientists at The Cancer Institute of New Jersey (CINJ) are now applying that knowledge to a process in which cancer cells eat themselves to downsize and resist therapy. The ultimate goal of this effort is to improve upon current anticancer treatments.
A new analysis of the National Cancer Institute's cancer registry has found that as many as one in five older women experience delayed or incomplete radiation treatment following breast-conserving surgery, and that this suboptimal care can lead to worse outcomes.
Vtesse, Inc. announced today that the U.S. Food and Drug Administration has granted its drug candidate, VTS-270 for treatment of Niemann-Pick Type C1 Disease (NPC), Breakthrough Therapy designation status. Both the FDA and the European Medicines Agency (EMA) had previously granted Orphan Drug status to VTS-270, which is currently in a pivotal Phase 2b/3 clinical trial.
Medical device company Vertos Medical, Inc., developer of the mildĀ® procedure for lumbar spinal stenosis (LSS), today announced it has completed a $15.5 million Series D financing. New investor, ONSET Ventures, led the round with additional participation from existing Vertos investors CHL Medical Partners, Foundation Medical Partners, Aweida Venture Partners and DFJ Mercury.
› Verified 7 days ago
Leah Wangeci Muthuri, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 625 Africa Rd Ste 240, Westerville, OH 43082 Phone: 614-508-2672 Fax: 614-508-2668 | |
Dr. John Joseph Ward, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 430 Altair Pkwy Ste 110, Westerville, OH 43082 Phone: 614-754-5500 Fax: 614-754-5501 | |
Nami L Cho, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 555 W Schrock Rd, Suite 110, Westerville, OH 43081 Phone: 614-882-0708 Fax: 614-882-2878 | |
Scott W Johnson, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 655 Africa Rd, Westerville, OH 43082 Phone: 614-326-2672 | |
Dr. David Brian Mcclure, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Polaris Pkwy, Ste 3400, Westerville, OH 43082 Phone: 614-533-3475 Fax: 614-533-3480 | |
John B Krupko, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 625 Africa Rd Ste 200, Westerville, OH 43082 Phone: 614-891-8080 Fax: 614-891-7078 | |
Michael J Dial, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 6100 N Hamilton Rd, Westerville, OH 43081 Phone: 614-814-8490 Fax: 614-814-8520 |